BRO vs ERNA · P/E 30, rev $4.80B vs P/E 0.0, rev $582.0K
Brown & Brown Inc (BRO) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the BRO and ERNA stock pages for the full models.
Not investment advice.